ABPA MINI panel(Allergic bronchopulmonary aspergillosis) Test in UAE

ABPA MINI Panel (Allergic Bronchopulmonary Aspergillosis) Test in Dubai and across the UAE to detect fungal hypersensitivity in asthma and cystic fibrosis patients. This specialized blood test helps diagnose ABPA — a serious allergic reaction to the Aspergillus fumigatus mold that can cause progressive lung damage if untreated. Combines key biomarkers for accurate detection. Results available within 5–7 days.

Overview

The ABPA MINI Panel is a targeted blood test used to diagnose Allergic Bronchopulmonary Aspergillosis (ABPA), a condition where the immune system overreacts to Aspergillus fumigatus, a common fungus found in dust and decaying organic matter. It primarily affects individuals with asthma or cystic fibrosis, leading to worsening respiratory symptoms and potential lung damage. The panel measures total IgE, Aspergillus-specific IgE, and Aspergillus precipitins (IgG) — key markers for confirming ABPA. Results are typically available within 5–7 business days.

Why You Need This Test

• Diagnose ABPA in patients with uncontrolled asthma or cystic fibrosis.
• Evaluate worsening cough, wheezing, or recurrent chest infections.
• Detect fungal sensitization before permanent lung damage occurs.
• Monitor disease progression or response to steroid/antifungal therapy.
• Rule out fungal bronchitis or aspergilloma in lung imaging abnormalities.
• Support early intervention to prevent bronchiectasis or pulmonary fibrosis.
• Available with home blood collection service across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Worsening asthma not responding to standard inhalers
• Chronic cough with brownish mucus plugs
• Wheezing and shortness of breath
• Fever or malaise without active infection
• Chest tightness or recurrent pneumonia-like episodes

Risk Factors

• Long-standing asthma, especially moderate to severe
• Cystic fibrosis (CF) — up to 15% develop ABPA
• High exposure to mold (e.g., farming, composting, damp environments)
• Elevated IgE levels on prior testing
• History of pulmonary infiltrates on chest X-ray or CT scan
• Smoking or lung structural damage

How the Test Works

The ABPA MINI Panel evaluates three critical immune markers to confirm fungal hypersensitivity:

• Total IgE: usually markedly elevated (>1000 IU/mL) in active ABPA.
• Aspergillus-specific IgE: detects allergic sensitization to Aspergillus fumigatus.
• Aspergillus precipitins (IgG): indicates chronic exposure and immune complex formation.

Used together, these markers help differentiate ABPA from simple fungal allergy or infection. The test is performed on a blood sample collected at home or in lab. Results are analyzed in certified pathology labs and delivered securely within 5–7 business days.

Sample Type

• We take: Venous blood sample (serum)
• Volume: 5–7 mL (1 red-top or serum separator tube)
• Collection method: standard venipuncture (arm draw)
• Home service available: trained phlebotomist collects sample at your residence
• Storage: sample kept at room temperature or refrigerated before lab processing
• Note: hemolyzed or severely lipemic samples may require recollection

Risks & Safety

• Minimal risk — standard blood draw with brief discomfort.
• No fasting or downtime required.
• Safe for adults and children with asthma or cystic fibrosis.
• Very low risk of bruising or infection at the puncture site.

Result Interpretation

Normal Range

• Total IgE: < 100 IU/mL (varies by age and lab)
• Aspergillus IgE: < 0.35 kU/L (negative)
• Aspergillus IgG (Precipitins): Not detected

Positive/Abnormal Results

• Suggestive of ABPA if:
  • Total IgE > 1000 IU/mL
  • Elevated Aspergillus-specific IgE
  • Presence of Aspergillus IgG precipitins
  • Clinical symptoms and imaging support diagnosis

Borderline or Inconclusive

• May require repeat testing, chest imaging (CT), or sputum culture.
• Follow-up with a pulmonologist or allergist is recommended.

Consequences if Untreated

• Progressive lung damage including bronchiectasis and fibrosis.
• Irreversible decline in lung function.
• Increased hospitalizations due to asthma exacerbations.
• Development of fungal balls (aspergillomas) in lung cavities.
• Reduced quality of life and exercise tolerance.

Factors Affecting Test Results

• Recent steroid use: may lower IgE levels and mask diagnosis.
• Antifungal medications: reduce fungal load and antibody levels.
• Other fungal allergies: possible cross-reactivity with other molds.
• Atopic conditions: high total IgE in eczema or allergic rhinitis.
• Timing: testing too early in disease course may yield false negatives.
• Lab variability: reference ranges may differ between testing platforms.

FAQs

Limitations

• Not a standalone diagnostic — must be combined with clinical symptoms, imaging, and pulmonary function tests.
• Steroid use can suppress IgE, leading to false-negative results.
• Does not detect active fungal infection — only allergic/immune response.
• May miss early-stage ABPA if markers are not yet elevated.
• Requires expert interpretation by a pulmonologist or immunologist.

Book Your ABPA MINI Panel Test Today

Don’t ignore worsening asthma or chronic cough — rule out fungal allergy early.

• Home Blood Collection Available (Across Dubai, Abu Dhabi, Sharjah & All Emirates)
• Comprehensive 3-Marker Panel for Accurate ABPA Screening
• Results in 5–7 Days
• Price: AED 475
• ✅ CLIA-Certified Labs | Allergy & Immunology Validated
• 🩸 Professional Phlebotomist at Home
• 🔒 Secure Digital Reporting